BioShield Announces Appointment of Atlanta's Renowned Dr. Scott Carroll to Board of AllergySuperstore.com.NORCROSS, Ga.--(BUSINESS WIRE)--May 12, 1999-- BioShield Technologies, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BSTI BSTI Bangladesh Standards and Testing Institute BSTI Basic Scientific and Technical Information ) announced today the appointment of Dr. Scott Carroll, current President and Senior Partner at Atlanta Allergy and Asthma Clinic where he has been in private practice for 26 years. Dr. Carroll also serves on the Steering Committee steer·ing committee n. A committee that sets agendas and schedules of business, as for a legislative body or other assemblage. steering committee Noun for Education Research and Trust Fund for the American Academy The American Academy in Berlin is a non-partisan academic institution in Berlin. It was founded in September 1994 by a group of prominent Americans and Germans, among them Richard Holbrooke, Henry Kissinger, Richard von Weizsäcker, Fritz Stern and Otto Graf Lambsdorff and opened in of Allergy. Commenting, Co-Chairman, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Timothy C. Moses said: "We are proud to have Dr. Carroll as a Board member. His experience and dedication makes him an invaluable asset to AllergySuperstore.com. Working with Mr. Chip Howes, our first Board member from Cisco Systems (NASDAQ NMS See NetWare Management System. : CSCO CSCO Cisco Systems Incorporated (stock symbol) CSCO Chief Supply Chain Officer ), we anticipate great success with our new subsidiary". BioShield Technologies, Inc. develops and markets antimicrobial and biostatic products for retail sale and for use in the industrial, environmental, and medical markets. Statements in this news release that are not historical are forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including, but not limited to, risks and uncertainties related to new developing technologies, dependence on collaborative partners, the inherent complexity and uncertainty regarding the development of products, BioShield's early stage development, the result of research and development efforts, future capital needs, and the uncertainty of additional funding and government regulations and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. BioShield does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion